- Home
- TNXP vs GLBZ Comparison
TNXP vs GLBZ Comparison
Compare TNXP & GLBZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNXP
- GLBZ
- Stock Information
- Founded
- TNXP 2007
- GLBZ 1949
- Country
- TNXP United States
- GLBZ United States
- Employees
- TNXP N/A
- GLBZ N/A
- Industry
- TNXP Biotechnology: Pharmaceutical Preparations
- GLBZ Major Banks
- Sector
- TNXP Health Care
- GLBZ Finance
- Exchange
- TNXP Nasdaq
- GLBZ Nasdaq
- Market Cap
- TNXP 19.5M
- GLBZ 17.3M
- IPO Year
- TNXP N/A
- GLBZ N/A
- Fundamental
- Price
- TNXP $0.20
- GLBZ $5.78
- Analyst Decision
- TNXP Strong Buy
- GLBZ
- Analyst Count
- TNXP 2
- GLBZ 0
- Target Price
- TNXP $53.50
- GLBZ N/A
- AVG Volume (30 Days)
- TNXP 51.5M
- GLBZ 4.6K
- Earning Date
- TNXP 11-12-2024
- GLBZ 10-31-2024
- Dividend Yield
- TNXP N/A
- GLBZ 7.33%
- EPS Growth
- TNXP N/A
- GLBZ N/A
- EPS
- TNXP N/A
- GLBZ 0.03
- Revenue
- TNXP $11,291,000.00
- GLBZ $11,317,000.00
- Revenue This Year
- TNXP $62.53
- GLBZ N/A
- Revenue Next Year
- TNXP $26.17
- GLBZ N/A
- P/E Ratio
- TNXP N/A
- GLBZ $170.97
- Revenue Growth
- TNXP 183.05
- GLBZ N/A
- 52 Week Low
- TNXP $0.12
- GLBZ $3.37
- 52 Week High
- TNXP $22.08
- GLBZ $7.16
- Technical
- Relative Strength Index (RSI)
- TNXP 66.43
- GLBZ 52.60
- Support Level
- TNXP $0.17
- GLBZ $5.53
- Resistance Level
- TNXP $0.28
- GLBZ $6.00
- Average True Range (ATR)
- TNXP 0.02
- GLBZ 0.24
- MACD
- TNXP 0.01
- GLBZ -0.00
- Stochastic Oscillator
- TNXP 44.53
- GLBZ 57.69
About TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.
About GLBZ Glen Burnie Bancorp
Glen Burnie Bancorp is a bank holding company for The Bank of Glen Burnie. It offers retail and commercial banking services such as checking, savings, loans, mobile banking, online banking, wire transfer, ACH services, debit cards, automated teller machines, and safe deposit boxes among others. The bank generates its revenue in the form of interest income. All of the revenues are earned within the United States.